These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1841810)

  • 1. [The current therapy of hypertension].
    Magnani B
    Cardiologia; 1991 Dec; 36(12 Suppl 1):85-8. PubMed ID: 1841810
    [No Abstract]   [Full Text] [Related]  

  • 2. More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension.
    Kjeldsen SE; Hedner T; Narkiewicz K; Oparil S
    Blood Press; 2008; 17(3):132-3. PubMed ID: 18665471
    [No Abstract]   [Full Text] [Related]  

  • 3. Current issues in hypertension research and therapy.
    MacFadyen RJ; Prasad N
    Br J Hosp Med; 1995 Apr 5-18; 53(7):335-43. PubMed ID: 7788073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Improving the control of systolic hypertension and pulse pressure in elderly population].
    Sun N
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1441-2. PubMed ID: 12645505
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetes technology news. Calcium antagonists aid high blood pressure control.
    Walczak IM
    Diabetes Technol Ther; 2003; 5(3):510-1. PubMed ID: 12838935
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hypertension in the year 2000: do we all agree?].
    Navazio F
    Clin Ter; 2000; 151(4):253-5. PubMed ID: 11107674
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of calcium channel blockers and angiotensin-converting enzyme inhibitors after cardiac transplantation.
    Rockx MA; Haddad H
    Curr Opin Cardiol; 2007 Mar; 22(2):128-32. PubMed ID: 17284992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hypertension in patients with diabetes mellitus.
    Agarwal R
    Indian Heart J; 2001; 53(3):361-9. PubMed ID: 11516043
    [No Abstract]   [Full Text] [Related]  

  • 9. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ACE inhibitors, calcium channel blockers and their combination on renal and extrarenal structures in renal failure.
    Amann K; Törnig J; Nichols C; Zeier M; Mall G; Ritz E
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():33-8. PubMed ID: 8643206
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined antihypertensive therapy: review of multicenter studies conducted in foreign countries].
    Shabalin AV; Nikitin IuP
    Ter Arkh; 1999; 71(8):74-8. PubMed ID: 10515043
    [No Abstract]   [Full Text] [Related]  

  • 12. Serial hemodynamic measurements allow better blood pressure control than clinical judgment in those with refractory hypertension.
    Basile J
    J Clin Hypertens (Greenwich); 2002; 4(6):434-5. PubMed ID: 12461310
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
    Linas S
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):15-9. PubMed ID: 2220796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trough-to-peak ratio of angiotensin converting enzyme inhibitors and calcium antagonists.
    Myers MG
    Am J Hypertens; 1997 May; 10(5 Pt 1):580-2. PubMed ID: 9160773
    [No Abstract]   [Full Text] [Related]  

  • 15. Does combination therapy with a calcium channel blocker and an ACE inhibitor have additive effects on blood pressure reduction?
    Edelman DA; Paul RA
    Int J Clin Pract; 2000 Mar; 54(2):105-9. PubMed ID: 10824365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of changes in blood pressure and left ventricular mass induced by antihypertensive treatment on ventricular arrhythmias in essential hypertension.
    Muiesan ML; Zulli R; Rizzoni D; Calebich S; Malerba M; Porteri E; Agabiti-Rosei E
    J Hypertens Suppl; 1993 Dec; 11(5):S104-5. PubMed ID: 8158296
    [No Abstract]   [Full Text] [Related]  

  • 17. Treating hypertension in the diabetic patient: therapeutic goals and the role of calcium channel blockers.
    Caldwell BV
    Clin Ther; 1993; 15(4):618-36; discussion 617. PubMed ID: 8221813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ACE inhibitors and calcium channel blockers on the development of glomerular sclerosis in models of renal damage.
    Raij L
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():23-7. PubMed ID: 8643203
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular disease.
    Mizuno Y; Jacob RF; Mason RP
    Am J Hypertens; 2008 Oct; 21(10):1076-85. PubMed ID: 18756260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension in an urban population--who is treated with what and how well?
    Li C; Hedblad B; Berglund G; Janzon L
    J Hum Hypertens; 2007 Apr; 21(4):323-6. PubMed ID: 17273156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.